Why do hospitals keep running out of generic drugs?Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.
US drug shortages reach record high with 323 meds now in short supplyDrug shortages in the US have hit a record high in 2023, with concerns around generic sterile injectables and ADHD therapies.
Why do hospitals keep running out of generic drugs?Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.
US drug shortages reach record high with 323 meds now in short supplyDrug shortages in the US have hit a record high in 2023, with concerns around generic sterile injectables and ADHD therapies.
Weight-loss drug boom sparks battle over pharmacy copycatsThe surge in compounded GLP-1 drugs addresses availability but leads to regulatory issues and legal battles.Compounding offers personalized medication options, even amidst drug shortages.
Drug makers can't make knockoff weight-loss drugs anymore-and they're madCompounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.
Ozempic knockoffs flood US market thanks to blind spot' in FDA rulesThe obscurity of a federal statute is enabling US pharmacies to flood the market with unvetted knockoffs of popular weight-loss drug Ozempic.
Weight-loss drug boom sparks battle over pharmacy copycatsThe surge in compounded GLP-1 drugs addresses availability but leads to regulatory issues and legal battles.Compounding offers personalized medication options, even amidst drug shortages.
Drug makers can't make knockoff weight-loss drugs anymore-and they're madCompounding pharmacies are suing the FDA to continue producing tirzepatide imitations despite the drug's supply improving.The FDA announced that the tirzepatide shortage has been resolved, impacting compounding pharmacies' operations.
Ozempic knockoffs flood US market thanks to blind spot' in FDA rulesThe obscurity of a federal statute is enabling US pharmacies to flood the market with unvetted knockoffs of popular weight-loss drug Ozempic.
Can More Vyvanse Production Ease the A.D.H.D. Drug Shortage?The DEA has increased Vyvanse production to address ongoing ADHD medication shortages, but experts doubt it will solve the issue completely.
The Future of Ozempic Will Be Riddled With DupesObesity drug shortages have driven people to risky, unregulated alternatives, posing serious health risks.
Eli Lilly warns about dangers of fake and counterfeit Mounjaro, ZepboundEli Lilly warns against fake and compounded diabetes and weight loss drugs, addresses concerns of shortages and health risks.
The Future of Ozempic Will Be Riddled With DupesObesity drug shortages have driven people to risky, unregulated alternatives, posing serious health risks.
Eli Lilly warns about dangers of fake and counterfeit Mounjaro, ZepboundEli Lilly warns against fake and compounded diabetes and weight loss drugs, addresses concerns of shortages and health risks.
A Proven Model to Combat U.S. Drug ShortagesDrug shortages in the US reach record highs, impacting over 300 essential medications. Civica Rx offers a successful model for addressing shortages.
Drug shortages, now normal in UK, made worse by Brexit, report warnsDrug shortages in the UK, worsened by Brexit, are a significant and growing issue affecting patients and healthcare professionals.
The Ozempic Revolution Is StuckObesity drugs like Wegovy were originally created for different purposes, now being repurposed for heart health.FDA approval of Wegovy for heart health could open access to more Americans, but drug shortages remain a significant barrier.
Big Pharma's Supply Chain is CRUMBLING as Drug Shortages Reach Decade HighDrug shortages in the U.S. are at the highest level in a decade, impacting various types of drugs for over three years on average.
Top doctor alarmed by weight-loss drug misuseNHS warns against the inappropriate use of weight-loss drugs without medical supervision.